Derivatives of the 16-membered dienlactone bafilomycins were prepared in order to study the structure-activity relationship of these compounds. Some derivatives formed by hydrolysis, O-alkylation, O-acylation, trans-esterification and epoxidation were isolated and their structures determined by two-dimensional (2D) NMRstudies and mass spectroscopy.
Acid or alkaline conditions, in the presence of moderately nucleophilic reagents, led to a number of products which themselves were found to be unstable and which decomposed during the isolation procedure. Nevertheless some derivatives of the native bafilomycins were finally isolated and their structures determined. Thus information on the chemical behavior of the bafilomycins under various reaction conditions could be obtained. The biological activity of the derivatives was determined.
Results and Discussion
The chemical reactivity of the natural bafilomycins (Al9 Bx and Q) and their general chemical behavior under different reaction conditions were studied by characterization of formed products and by-products. Major chemical reaction types which were found suitable for producing derivatives of the labile bafilomycins are ; hydrolytic In comparision with bafilomycin Ai all derivatives described exhibit lower antibacterial, antifungal and insecticidal activities.
Hydrolytic Reactions Bafilomycin D can be obtained by alkaline hydrolysis of a solution of bafilomycins Bx and Q in dioxane -water (5 : 1)3). The alkaline hydrolysis of C(19)-0-methyl bafilomycin Q (Fig. 2) in MeOHwith 1 n NaOHled to bafilomycin Vx (1) . The ester-bond at C(21) was cleaved and a trans-esterification at C(l) gave the open-chain methyl ester (1) . In aqueous acidic methanolic solution, 1 yielded the hemiketals bafilomycin V2' (20 and V2" (2"). The two diastereomers could be separated by chromatography. During the preparation of V2' and V2", ' the C(20)/C(21) dehydrated hemiketal bafilomycin V3 (3) was formed also. (Fig. 3) . During the preparation of 6, bafilomycin W (7) which is the C(17)/C(18) dehydrated form of 6 was formed too. C(21)-0-Methyl bafilomycin A1 is most likely identical with L-681,110 Bi isolated from Streptomyces sp. MA-5038 by Hensens et alfi. Reaction of C(19)-O-methyl bafilomycin Q with diazomethane in methanolic solution led to the corresponding methyl ester (10). By reaction of bafilomycin Axor 4 with citraconic anhydride, maleic anhydride and cyclohexane-1,2-dicarbonic anhydride the C(21)-0-acyl bafilomycins (12, 13 and 14) were obtained (Fig. 4) .
Reaction of bafilomycin Ax and 4 with different carboxylic acid chlorides {e.g. bromoacetyl chloride, /j-toluenesulfonyl chloride, benzoyl chloride, isovaleryl chloride, methylmalonyl chloride, hexane-1 ,6-dicarbonyl chloride) under the above mentioned reaction conditions, led to a mixture of products. In all cases the major component formed was 15 which was isolated and shown to be the 3-fold dehydrated form of bafilomycin Ax (Fig. 4) . The other products formed were too unstable to be isolated. Epoxidation Bafilomycin B-l was transformed by reaction with m-chloroperbenzoic acid (Fig. 5 ) into the C(10)/ C(l 1) oxiran (16). The reaction conditions were found to be of low regio-selectivity since other oxirans of bafilomycin Bx were detected by mass spectroscopy in the crude reaction product.
Exp erimental
The reactions were monitored by TLCand HPLC. Analytical thin-layer chromatography was carried out on Silica gel plates (60F254, Merck) developed with a mixture of CH2C12 -MeOH(9 :1, solvent A) or CH2C12 -MeOH(97:3, solvent B) and the spots detected by UV light as 254nm and by spraying with 18% methanolic HC1 (pink color reaction).
Analytical HPLCwas performed on reversed phase columns (Shandon ODSHypersil 5^m, 4 .6x 125 mm) using CH3CN-MeOH-0.017 m aq tetrabutylammonium phosphate (240 :225 : 145) as a solvent system, (flow rate 1~3 ml/minute, UVdetection at 254 nm).
Purification of Compounds Preparative HPLCwas carried out on reversed phase columns (Merck LiChrosorb RP 18 10^m, 32 x250 mm) (method I) and (Dynamax C18 7 /^m, 21.4 x250 mm) (method II) using various stepwise gradients of MeOH-H2O from (70 :30) to MeOH-H2O (90 : 10) at pH 8.
Column chromatography on silica gel was carried out on Lobar columns (Merck, size A and B) (method III).
Preparative TLC was carried out on Silica gel plates (60F254, 20 x 20 x 0.2cm, Merck) (method IV).
UVspectra were recorded on a Perkin-Elmer Lambda5 and on a Kontron Uvicon 860. NMR spectra were measured with a Bruker AM300 and a Bruker WM400. Fast atom bombardment mass spectra (FAB-MS)were recorded with a Kratos MS80 and negative chemical ionization mass spectra (NCI-MS) with a Finnigan MAT8230.
The purity of the compounds described was tested by HPLCand TLC and was >95 %in all cases. Bafilomycin Vx (1) To a solution of C(19)-<3-methyl bafilomycin Q (370mg) in MeOH(40ml) 2ml I n NaOH were added dropwise. The reaction mixture was stirred for 15 minutes at 60°C, subsequently cooled in an ice bath to 5°C and neutralized with acetic acid. The solution was evaporated to dryness. The crude product was purified on reversed phase HPLC(method I) using MeOH-H2O (80 : 20) as eluant. After lyophilization from a benzene solution 1 (180 mg, white powder) was obtained. Bafilomycin V2 (27 +2") A solution of 1 (90mg) in MeOH-AcOH -H2O (90:5 :5, 30ml) was stirred 30 minutes at 50°C. The reaction mixture was neutralized with NaHCO3, filtered and evaporated to dryness. The purification by reversed phase chromatography (method I) gave a mixture of 2' and 2" (62 mg). Chromatography on silica gel (method III) with CHC13 -MeOH(9 : 1) as eluant yielded after lyophilization from a benzene solution 2' (36 mg, white powder) and 2" (21 mg, white powder). This compound was prepared by the procedure described for 2' and 2", treating 1 (62 mg) with 
(21)-O-Ethyl
Bafilomycin A, (9) A solution of bafilomycin Ax (150 mg) in EtOH -phosphoric acid (5% in vol, 15 ml) was stirred 1 hour at room temperature. The purification was carried out as described for 8. After lyophilization from a benzene solution 9 (62 mg white powder) was obtained.
* (2 g) was stirred 2 hours in DMSO(16 ml) at 65°C. Bafilomycin Bx (500 mg) in 3 ml DMSOwas added and stirred 30 minutes at room temperature. After dropwise addition of 14 ml methyl iodide, the solution was stirred for 15 hours in the dark at room temperature. The reaction mixture was poured into 100 ml H2Oand extracted three times with 50 ml dichloromethane. The separated organic layer was washed with H2O and Na2S2O3 (3 %), dried over Na2SO4 and evaporated to dryness. The material was chromatographed on silica gel (method III) with CH2C12-MeOH (98 : 2) as eluant. Yield of ll: 70 mg (yellow microcrystalline powder). Bafilomycin Z (15) To a solution of bafilomycin Ax (310 mg, 0.5 mmol) in anhydrous dichloromethane (20 ml), 2,6-di-ter£-butylpyridine (204 mg, 1 mmol) was added, followed by dropwise addition of a solution of bromoacetylchloride (66 jul, 0.8 mmol) in THF (2 ml) at -20°C. The reaction mixture was stirred 2 hours at -10°C and 24 hours at room temperature. The solution was poured into ice water and extracted twice with 20 ml dichloromethane. The organic layer was washed twice with a saturated NaHCO3solution, twice with a saturated aqueous NaCl solution, dried over Na2SO4, and evaporated to dryness. Preparative TLC on five silica gel plates (method IV) with CHC13 -Me2CO (98 :2) as eluant yielded 14 (47 mg, white powder).
*H NMR (CDCI3) 8 6.02 (H-17), 5.75 (H-21), 5.28 (H-20), 1.79 (CH8-31, CH3-32); 13C NMR (CDCI3) 8 150.7 (C-19), 130.2 (C-l8), 127.9 (C-22), 124.7 (C-l7), 118.6 (C-21), 98.9 (C-20); NCI-MS m\z 568 (M-, C35H50O6); UV ffi°H nm (e) 244 (16,800), 285 (9,800); TLC (solvent B) Rf 0.77. Bafilomycin B1-C(10)/C(l l)-oxiran (16) To a solution of bafilomycin Bx (420 mg, 0.5 mmol) in trichloromethane (10 ml), 0.138 ml triethylamine was added. After dropwise addition of m-chloroperbenzoic acid (200 mg, 1 mmol) at -10°C, the mixture was stirred 1 hour at this temperature and an additional 2 hours at room temperature. After addition of sodium dithionite (200 mg), the mixture was stirred for 1 hour at room temperature, filtered and evaporated to dryness in vacuo. The residue was dissolved in trichloromethane (10 ml), washed three times with 1 % aq NaHCO3 solution (10 ml), dried over Na2SO4 and evaporated MAR. 1987 to dryness. After purification on reversed phase HPLC(method I) with a gradient from H2O-MeOH (9 : 1) to MeOH16 (60 mg, yellow, microcrystalline) was obtained. 
